Merck HPV Vaccine Gardasil Shows 100% Efficacy In Phase III Primary Analysis

 
• By Mary Bruce

Merck plans to submit a BLA for the cervical cancer vaccine in the fourth quarter.

More from Archive

More from Pink Sheet